Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up for diagnosis, referral and treatment of the sleep disorders collected, tailored to patients in this population.

This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cell Lung Cancer Mental Disorders Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Sleep Disorders Sleep Wake Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

HUS

Strasbourg, Grand Est, 67117, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient aged 18 and over.
Being monitored and treated for non-small cell lung cancer.
With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG <2).
Able to understand the study documents written in French
Able to complete the study questionnaires written in French.
Contactable by telephone throughout the study
Affiliated to a social security scheme or entitled beneficiary
Not opposed to taking part in the study

Exclusion criteria

Patient refusing to take part in the study
With a mental illness of the psychosis type monitored and treated prior to the study
Patient under guardianship or curatorship
Patient under court protection

Treatment and study plan

self-questionnaires exploring

Other

At each stage, subjects are asked to fill in self-questionnaires exploring the quality of their sleep, their potential distressing symptoms, their psychological state and the quality of their life at that moment. They complete the self-questionnaires at t

Primary outcomes

Score sleep quality criteria (Pittsburgh Sleep Quality Index)

Time frame: Every 14 days for 2 months

The overall score ranging from 0 to 21 points. A score of 0 means that there is no difficulty sleeping, and 21 indicates, on the contrary, major difficulties.

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: SomOncoP

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Jul 10, 2024
Registry last updated: Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed